Mesoblast
MESO
30 hedge funds and large institutions have $18.6M invested in Mesoblast in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
39% more capital invested
Capital invested by funds: $13.3M → $18.6M (+$5.26M)
15% more funds holding
Funds holding: 26 → 30 (+4)
0.01% more ownership
Funds ownership: 0.26% → 0.27% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
94% less call options, than puts
Call options by funds: $8K | Put options by funds: $125K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$375K |
| 2 |
Jane Street
New York
|
+$276K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$163K |
| 4 |
WSTAM
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
+$130K |
| 5 |
JP Morgan Chase
New York
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$588K |
| 2 |
OWD
Osborn Williams & Donohoe
Cincinnati,
Ohio
|
-$133K |
| 3 |
Renaissance Technologies
New York
|
-$112K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24.9K |
| 5 |
PM
Penbrook Management
New York
|
-$8.81K |
MESO Hedge Fund Activity: Q3 2019 in Review
30 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2019, worth a combined $18.6M — up 39% from $13.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MESO positions and 4 closed out — a net gain of 4 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $375K. The largest seller was Morgan Stanley, cutting an estimated $588K.
- 30 institutional investors held Mesoblast (MESO) as of Q3 2019, up from 26 in Q2 2019.
- Funds reported $18.6M of Mesoblast stock for Q3 2019, up 39% quarter-over-quarter.
- 8 funds opened new Mesoblast positions in Q3 2019 and 4 closed out, a net change of +4 holders.
- The largest Mesoblast buyer in Q3 2019 was Susquehanna International Group, an estimated $375K added.
- The largest Mesoblast seller in Q3 2019 was Morgan Stanley, an estimated $588K sold.
Based on aggregated 13F filings for Q3 2019.